Top ▲
Target not currently curated in GtoImmuPdb
Target id: 1966
Nomenclature: cyclin dependent kinase 13
Abbreviated Name: CDK13
Family: CRK7 subfamily
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 1512 | 7p14.1 | CDK13 | cyclin dependent kinase 13 | |
Mouse | - | 1511 | 13 A2 | Cdk13 | cyclin dependent kinase 13 | |
Rat | - | 1511 | 17 q12.1 | Cdk13 | cyclin-dependent kinase 13 |
Previous and Unofficial Names |
CDC2L | CDC2L5 | CDC2-related protein kinase 5 | cell division cycle 2-like 5 | cell division protein kinase 13 |
Database Links | |
Alphafold | Q14004 (Hs), Q69ZA1 (Mm) |
BRENDA | 2.7.11.22, 2.7.11.23 |
ChEMBL Target | CHEMBL1795192 (Hs) |
Ensembl Gene | ENSG00000065883 (Hs), ENSMUSG00000041297 (Mm), ENSRNOG00000013620 (Rn) |
Entrez Gene | 8621 (Hs), 69562 (Mm), 306998 (Rn) |
Human Protein Atlas | ENSG00000065883 (Hs) |
KEGG Enzyme | 2.7.11.22, 2.7.11.23 |
KEGG Gene | hsa:8621 (Hs), mmu:69562 (Mm), rno:306998 (Rn) |
OMIM | 603309 (Hs) |
Pharos | Q14004 (Hs) |
RefSeq Nucleotide | NM_003718 (Hs), NM_027118 (Mm), NM_001271295 (Rn) |
RefSeq Protein | NP_003709 (Hs), NP_001074527 (Mm), NP_001258224 (Rn) |
UniProtKB | Q14004 (Hs), Q69ZA1 (Mm) |
Wikipedia | CDK13 (Hs) |
Enzyme Reaction | ||||||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||
|
DiscoveRx KINOMEscan® screen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 1,3 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: CDC2L5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
Immuno Process Associations | ||
|
||
|
||
|
1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
2. Ito M, Tanaka T, Toita A, Uchiyama N, Kokubo H, Morishita N, Klein MG, Zou H, Murakami M, Kondo M et al.. (2018) Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors. J Med Chem, 61 (17): 7710-7728. [PMID:30067358]
3. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
CRK7 subfamily: cyclin dependent kinase 13. Last modified on 28/08/2018. Accessed on 11/10/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1966.